# PharmaCyte Biotech, Inc.: filings

PMCB · Nasdaq · CIK 1157075 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/pmcb.md) · [Financials](/companies/pmcb/financials.md) · [Filings](/companies/pmcb/filings.md) · [Insiders](/companies/pmcb/insiders.md)

## Reports and events: 210 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 94, 10-Q 54, UPLOAD 27, 4 25, CORRESP 25, 3 19, 10-K 18, NT 10-K 12, NT 10-Q 12, 10-Q/A 11, 8-K/A 8, 10-K/A 7, DEF 14A 7, DEFA14A 7, SC 13G/A 7, 424B5 6, EFFECT 6, S-3 6, SC 13D/A 6, PRE 14A 5, SC 13G 5, 4/A 4, D 4, DFAN14A 4, S-3/A 4, SC 13D 4, SCHEDULE 13G/A 4, ARS 3, 424B3 2, CT ORDER 2, 424B2 1, 425 1, 8-A12B 1, CERT 1, NTN 10Q 1, PREC14A 1, S-3MEF 1, S-8 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 21:00 ET | [8-K](/filings/0001683168-26-007934.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-26-007934 |
| 2026-09-14 | 20:05 ET | [10-Q](/filings/0001683168-26-007106.md) | Quarterly report, period 2026-07-31 | 0001683168-26-007106 |
| 2026-07-29 | 20:58 ET | [10-K](/filings/0001683168-26-005836.md) | Annual report, period 2026-04-30 | 0001683168-26-005836 |
| 2026-04-02 | 20:19 ET | [8-K](/filings/0001683168-26-002613.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-26-002613 |
| 2026-03-17 | 19:49 ET | [10-Q](/filings/0001683168-26-001917.md) | Quarterly report, period 2026-01-31 | 0001683168-26-001917 |
| 2026-03-09 | 10:02 ET | [DEF 14A](/filings/0001683168-26-001593.md) | Proxy statement, period 2026-03-30 | 0001683168-26-001593 |
| 2025-12-18 | 22:04 ET | [10-Q](/filings/0001683168-25-009259.md) | Quarterly report, period 2025-10-31 | 0001683168-25-009259 |
| 2025-12-05 | 22:00 ET | [8-K](/filings/0001683168-25-008947.md) | 3.01 Delisting notice | 0001683168-25-008947 |
| 2025-11-18 | 21:29 ET | [SCHEDULE 13D/A](/filings/0001683168-25-008515.md) | Ownership report, active investor, amended | 0001683168-25-008515 |
| 2025-11-18 | 21:05 ET | [8-K/A](/filings/0001683168-25-008512.md) | 9.01 Financial statements and exhibits | 0001683168-25-008512 |
| 2025-10-31 | 20:05 ET | [8-K](/filings/0001683168-25-007871.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-25-007871 |
| 2025-10-06 | 21:08 ET | [DEF 14A](/filings/0001683168-25-007435.md) | Proxy statement, period 2025-10-30 | 0001683168-25-007435 |
| 2025-09-15 | 20:37 ET | [10-Q](/filings/0001683168-25-006991.md) | Quarterly report, period 2025-07-31 | 0001683168-25-006991 |
| 2025-09-05 | 20:05 ET | [8-K](/filings/0001683168-25-006727.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-006727 |
| 2025-08-18 | 13:20 ET | [8-K](/filings/0001683168-25-006274.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-006274 |
| 2025-08-11 | 21:46 ET | [10-K](/filings/0001683168-25-005821.md) | Annual report, period 2025-04-30 | 0001683168-25-005821 |
| 2025-04-24 | 20:47 ET | [8-K](/filings/0001683168-25-002790.md) | 5.07 Shareholder vote results | 0001683168-25-002790 |
| 2025-03-17 | 21:22 ET | [10-Q](/filings/0001683168-25-001669.md) | Quarterly report, period 2025-01-31 | 0001683168-25-001669 |
| 2025-03-10 | 20:17 ET | [DEF 14A](/filings/0001683168-25-001464.md) | Proxy statement, period 2025-04-24 | 0001683168-25-001464 |
| 2025-02-26 | 18:57 ET | [8-K](/filings/0001683168-25-001236.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-001236 |
| 2024-12-13 | 21:01 ET | [10-Q](/filings/0001683168-24-008709.md) | Quarterly report, period 2024-10-31 | 0001683168-24-008709 |
| 2024-09-17 | 00:47 ET | [10-Q](/filings/0001683168-24-006441.md) | Quarterly report, period 2024-07-31 | 0001683168-24-006441 |
| 2024-08-13 | 20:37 ET | [10-K](/filings/0001683168-24-005575.md) | Annual report, period 2024-04-30 | 0001683168-24-005575 |
| 2024-05-30 | 20:05 ET | [SC 13D](/filings/0001683168-24-003883.md) | Ownership report, active investor | 0001683168-24-003883 |
| 2024-05-23 | 20:40 ET | [8-K](/filings/0001683168-24-003796.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-003796 |
| 2024-05-01 | 20:05 ET | [8-K](/filings/0001683168-24-002881.md) | 5.07 Shareholder vote results | 0001683168-24-002881 |
| 2024-03-27 | 20:06 ET | [DEF 14A](/filings/0001683168-24-001762.md) | Proxy statement, period 2024-04-29 | 0001683168-24-001762 |
| 2024-03-18 | 20:02 ET | [10-Q](/filings/0001683168-24-001525.md) | Quarterly report, period 2024-01-31 | 0001683168-24-001525 |
| 2023-12-15 | 22:25 ET | [10-Q](/filings/0001683168-23-008889.md) | Quarterly report, period 2023-10-31 | 0001683168-23-008889 |
| 2023-11-24 | 21:00 ET | [8-K](/filings/0001683168-23-008446.md) | 5.02 Departure or appointment of officers or directors | 0001683168-23-008446 |
| 2023-11-22 | 21:00 ET | [SC 13D](/filings/0001683168-23-008419.md) | Ownership report, active investor | 0001683168-23-008419 |
| 2023-11-16 | 01:45 ET | [8-K](/filings/0001683168-23-008204.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-008204 |
| 2023-11-09 | 22:25 ET | [8-K](/filings/0001683168-23-007830.md) | 4.01 Change of auditor | 0001683168-23-007830 |
| 2023-09-18 | 10:04 ET | [10-Q](/filings/0001683168-23-006505.md) | Quarterly report, period 2023-07-31 | 0001683168-23-006505 |
| 2023-09-07 | 20:05 ET | [8-K](/filings/0001683168-23-006331.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-23-006331 |
| 2023-08-04 | 20:01 ET | [8-K](/filings/0001683168-23-005293.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-23-005293 |
| 2023-07-31 | 21:18 ET | [10-K](/filings/0001683168-23-005175.md) | Annual report, period 2023-04-30 | 0001683168-23-005175 |
| 2023-07-31 | 20:42 ET | [DEF 14A](/filings/0001683168-23-005167.md) | Proxy statement, period 2023-08-31 | 0001683168-23-005167 |
| 2023-07-19 | 23:05 ET | [8-K](/filings/0001683168-23-004985.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-004985 |
| 2023-06-16 | 21:22 ET | [SC 13D/A](/filings/0000921895-23-001535.md) | Ownership report, active investor, amended | 0000921895-23-001535 |
| 2023-06-05 | 20:05 ET | [DEF 14A](/filings/0001683168-23-003905.md) | Proxy statement, period 2023-06-05 | 0001683168-23-003905 |
| 2023-05-12 | 20:22 ET | [SC 13D/A](/filings/0000921895-23-001173.md) | Ownership report, active investor, amended | 0000921895-23-001173 |
| 2023-05-11 | 12:30 ET | [8-K](/filings/0001683168-23-003169.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-003169 |
| 2023-03-16 | 20:42 ET | [10-Q](/filings/0001683168-23-001559.md) | Quarterly report, period 2023-01-31 | 0001683168-23-001559 |
| 2023-02-02 | 14:15 ET | [8-K](/filings/0001683168-23-000500.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-000500 |
| 2022-12-30 | 21:05 ET | [8-K](/filings/0001683168-22-008705.md) | 5.07 Shareholder vote results | 0001683168-22-008705 |
| 2022-12-14 | 22:19 ET | [10-Q](/filings/0001683168-22-008428.md) | Quarterly report, period 2022-10-31 | 0001683168-22-008428 |
| 2022-11-25 | 13:08 ET | [DEF 14A](/filings/0001683168-22-008032.md) | Proxy statement, period 2022-12-28 | 0001683168-22-008032 |
| 2022-11-18 | 21:01 ET | [8-K](/filings/0001683168-22-007894.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-22-007894 |
| 2022-11-07 | 22:00 ET | [8-K](/filings/0001683168-22-007359.md) | 5.02 Departure or appointment of officers or directors | 0001683168-22-007359 |

Page 1 of 5. [Older](/companies/pmcb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.